Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 230

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis

Open access
Waksman, Ron, Rogers, Toby, Torguson, Rebecca, Gordon, Paul, Ehsan, Afshin, Wilson, Sean R., Goncalves, John, Levitt, Robert, Hahn, Chiwon, Parikh, Puja, Bilfinger, Thomas, Butzel, David, Buchanan, Scott, Hanna, Nicholas, Garrett, Robert, Asch, Federico, Weissman, Gaby, Ben-Dor, Itsik, Shults, Christian, Bastian, Roshni, Craig, Paige E., Garcia-Garcia, Hector M., Kolm, Paul, Zou, Quan, Satler, Lowell F., Corso, Paul J. · 2018 · Journal of the American College of Cardiology

Abstract

BACKGROUND Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with symptomatic severe aortic stenosis who are extreme, high, or intermediate risk for surgical aortic valve replacement (SAVR). OBJECTIVES The authors sought to evaluate TAVR in a prospective multicenter trial involving low-risk patients. METHODS The Low Risk TAVR (Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis) trial was the first U.S. Food and Drug Administration-approved Investigational Device Exemption trial to enroll in the United States. This investigator-led trial was a prospective, multicenter, unblinded, comparison to historical controls from the Society of Thoracic Surgeons (STS) database. The primary endpoint was all-cause mortality at 30 days. RESULTS The authors enrolled 200 low-risk patients with symptomatic severe aortic stenosis at 11 centers to undergo TAVR. The authors compared outcomes with an inverse probability weighting-adjusted control cohort of 719 patients who underwent SAVR at the same institutions using the STS database. At 30 days, there was zero all-cause mortality in the TAVR group versus 1.7% mortality in the SAVR group. There was zero in-hospital stroke rate in the TAVR group versus 0.6% stroke in the SAVR group. Permanent pacemaker implantation rates were similar between TAVR and SAVR (5.0% vs. 4.5%). The rates of new-onset atrial fibrillation (3.0%) and length of stay (2.0 ± 1.1 days) were low in the TAVR group. One patient (0.5%) in the TAVR group had >mild paravalvular leak at 30 days. Fourteen percent of TAVR patients had evidence of subclinical leaflet thrombosis at 30 days. CONCLUSIONS TAVR is safe in low-risk patients with symptomatic severe aortic stenosis, with low procedural complication rates, short hospital length of stay, zero mortality, and zero disabling stroke at 30 days. Subclinical leaflet thrombosis was observed in a minority of TAVR patients at 30 days. (Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis [Low Risk TAVR; NCT02628899).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.08.1033

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 230

Metadata

Authors
Waksman, R., Rogers, T., Torguson, R., Gordon, P., Ehsan, A., Wilson, S. R., Goncalves, J., Levitt, R., Hahn, C., Parikh, P., Bilfinger, T., Butzel, D., Buchanan, S., Hanna, N., Garrett, R., Asch, F., Weissman, G., Ben-Dor, I., Shults, C., Bastian, R., Craig, P. E., Garcia-Garcia, H. M., Kolm, P., Zou, Q., Satler, L. F., & Corso, P. J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2018-10
Volume
72
Issue
18
Pages
2095-2105
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2888943477
Cited by
230
References
3
FWCI
25.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. https://app.cochat.ai/papers/10.1016/j.jacc.2018.08.1033
The paper
Waksman, R., Rogers, T., Torguson, R., Gordon, P., Ehsan, A., Wilson, S. R., Goncalves, J., Levitt, R., Hahn, C., Parikh, P., Bilfinger, T., Butzel, D., Buchanan, S., Hanna, N., Garrett, R., Asch, F., Weissman, G., Ben-Dor, I., Shults, C., . . . Corso, P. J. (2018). Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2018.08.1033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.